Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€12.16

€12.16

0.830%
0.1
0.830%
-
 
23.08.24 / Tradegate WKN: 870378 / Name: Semperit / Stock / Automobiles & Auto Parts / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Semperit

sharewise wants to provide you with the best news and tools for Semperit, so we directly link to the best financial data sources.

News

EQS-News: Semperit increases profitability in the first half of 2024
EQS-News: Semperit increases profitability in the first half of 2024
EQS-News: Semperit increases profitability in the first half of 2024
EQS-News: Semperit finalizes sale of the remaining medical business
EQS-News: Semperit finalizes sale of the remaining medical business
EQS-News: Semperit finalizes sale of the remaining medical business
EQS-News: Semperit: Executive Board Chairman Karl Haider will not extend his contract
EQS-News: Semperit: Executive Board Chairman Karl Haider will not extend his contract
EQS-News: Semperit: Executive Board Chairman Karl Haider will not extend his contract
EQS-Adhoc: Semperit AG Holding: Executive Board Chairman Karl Haider will not extend his contract
EQS-Adhoc: Semperit AG Holding: Executive Board Chairman Karl Haider will not extend his contract
EQS-Adhoc: Semperit AG Holding: Executive Board Chairman Karl Haider will not extend his contract
EQS-News: Semperit with stable revenue and 9% EBITDA increase in Q1 2024
EQS-News: Semperit with stable revenue and 9% EBITDA increase in Q1 2024
EQS-News: Semperit with stable revenue and 9% EBITDA increase in Q1 2024
EQS-News: Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business
EQS-News: Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business
EQS-News: Semperit strengthened for further growth after transformation year – earnings 2023 still burdened by sold medical business
EQS-Adhoc: Semperit AG Holding: Semperit Executive Board proposes dividend of EUR 0.5 per share for 2023
EQS-Adhoc: Semperit AG Holding: Semperit Executive Board proposes dividend of EUR 0.5 per share for 2023
EQS-Adhoc: Semperit AG Holding: Semperit Executive Board proposes dividend of EUR 0.5 per share for 2023